The Contraceptives market based on Hormones or Spermicides in Ukraine has shown fluctuating trends over the past decade. From 2013 to 2023, there was an overall decline with occasional spikes, reaching $42.988 million in 2023. Notably, the year-on-year variation saw significant shifts, particularly the -9.84% drop in 2022, and a slight dip of -0.81% in 2023. The compound annual growth rate (CAGR) over the last five years also exhibited a declining trend at -0.71%, indicating an overall decrease in market value.
Key trends for future watch include:
- Potential market recovery post-2023 due to increasing awareness and usage of contraceptives.
- Impact of economic and political stability in Ukraine on consumer purchasing power.
- Innovations and advancements in hormonal contraceptive methods that may drive market growth.
How does Ukraine rank in Contraceptives (Based on Hormones or Spermicides) Market Size Value?
| # | 17 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 483,630,000 | 2023 | -0.78% | -0.58% | View data |
| 2 | 2 Argentina | 368,560,000 | 2023 | +2.14% | +3.2% | View data |
| 3 | 3 Italy | 242,670,000 | 2023 | -8.82% | -9.17% | View data |
| 4 | 4 Spain | 214,090,000 | 2023 | -11.7% | -7.16% | View data |
| 5 | 5 Chile | 123,060,000 | 2023 | -0.61% | -1.89% | View data |
| 7 | 7 Poland | 65,882,000 | 2023 | -6.03% | -4.93% | View data |
| 8 | 8 Switzerland | 62,127,000 | 2023 | -5.57% | -3.62% | View data |
| 9 | 9 Ukraine | 42,988,000 | 2023 | -0.81% | -0.71% | |
| 10 | 10 New Zealand | 28,129,000 | 2023 | +2.59% | +3.2% | View data |
| 11 | 11 Guatemala | 20,869,000 | 2023 | -9.52% | -9.55% | View data |
